Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT05340634
Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.
Phase: Phase 4
Role: Lead Sponsor
Start: Apr 20, 2020
Completion: Feb 2, 2022